PT1146117E - Um método para a produção de preparações de células endócrinas pancreáticas maduras e imaturas, a preparação de células e seu uso para tratamento de diabetes mellitus - Google Patents

Um método para a produção de preparações de células endócrinas pancreáticas maduras e imaturas, a preparação de células e seu uso para tratamento de diabetes mellitus Download PDF

Info

Publication number
PT1146117E
PT1146117E PT00201326T PT00201326T PT1146117E PT 1146117 E PT1146117 E PT 1146117E PT 00201326 T PT00201326 T PT 00201326T PT 00201326 T PT00201326 T PT 00201326T PT 1146117 E PT1146117 E PT 1146117E
Authority
PT
Portugal
Prior art keywords
endocrine cells
treatment
diabetes mellitus
mature
pancreatic endocrine
Prior art date
Application number
PT00201326T
Other languages
English (en)
Original Assignee
Beta Cell N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Cell N V filed Critical Beta Cell N V
Publication of PT1146117E publication Critical patent/PT1146117E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT00201326T 2000-04-12 2000-04-12 Um método para a produção de preparações de células endócrinas pancreáticas maduras e imaturas, a preparação de células e seu uso para tratamento de diabetes mellitus PT1146117E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201326A EP1146117B1 (en) 2000-04-12 2000-04-12 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
CA2363971A CA2363971C (en) 2000-04-12 2001-11-26 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
PT1146117E true PT1146117E (pt) 2008-05-06

Family

ID=32070512

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00201326T PT1146117E (pt) 2000-04-12 2000-04-12 Um método para a produção de preparações de células endócrinas pancreáticas maduras e imaturas, a preparação de células e seu uso para tratamento de diabetes mellitus

Country Status (8)

Country Link
US (1) US6686197B2 (pt)
EP (1) EP1146117B1 (pt)
AT (1) ATE384781T1 (pt)
CA (1) CA2363971C (pt)
DE (1) DE60037876T2 (pt)
DK (1) DK1146117T3 (pt)
ES (1) ES2299417T3 (pt)
PT (1) PT1146117E (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2465950A1 (en) * 2001-11-09 2003-05-15 Artecel Sciences, Inc. Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
US20040005301A1 (en) * 2002-02-12 2004-01-08 Goldman Steven A. Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
EP1636348B1 (en) 2003-06-20 2009-07-29 Vrije Universiteit Brussel VUB Method of generating islet beta-cells from exocrine pancreatic cells
SG193615A1 (en) 2011-03-29 2013-11-29 Beta Cell Nv Method for encapsulated therapeutic products and uses thereof
WO2013060893A1 (en) * 2011-10-28 2013-05-02 Centre National De La Recherche Scientifique Process of diagnostic, prognostic and therapeutic monitoring of solid tumors
JP6420323B2 (ja) * 2013-09-19 2018-11-07 ベタ−セル エンフェーＢｅｔａ−Ｃｅｌｌ Ｎｖ 糖尿病の治療方法
AU2014326794B2 (en) 2013-09-24 2019-03-21 Giner, Inc. System for gas treatment of a cell implant
BR112019009712A2 (pt) 2016-11-15 2019-08-13 Giner Life Sciences Inc dispositivo de difusão gasosa percutânea adequado para uso com um implante subcutâneo
CN110831656A (zh) 2017-05-04 2020-02-21 吉纳生命科学公司 稳健的可植入气体递送装置和方法、系统以及包括该装置的装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5050612A (en) * 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
US5858973A (en) * 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US6110743A (en) * 1995-02-10 2000-08-29 The Regents Of The University Of California Development and use of human pancreatic cell lines

Also Published As

Publication number Publication date
EP1146117B1 (en) 2008-01-23
DE60037876D1 (de) 2008-03-13
US20020177228A1 (en) 2002-11-28
US6686197B2 (en) 2004-02-03
ATE384781T1 (de) 2008-02-15
DE60037876T2 (de) 2009-01-29
ES2299417T3 (es) 2008-06-01
CA2363971C (en) 2011-10-11
CA2363971A1 (en) 2003-05-26
EP1146117A1 (en) 2001-10-17
DK1146117T3 (da) 2008-05-26

Similar Documents

Publication Publication Date Title
WO2002040630A3 (en) Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
ZA200301466B (en) Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells.
PT1146117E (pt) Um método para a produção de preparações de células endócrinas pancreáticas maduras e imaturas, a preparação de células e seu uso para tratamento de diabetes mellitus
AU1112202A (en) Preparation and xenotransplantation or porcine islets
HK1096691A1 (en) Process for the preparation of a highly pure albumin solution
WO2002078449A3 (en) Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
WO2003100026A3 (en) Methods, compositions, and growth and differentiation factors for insulin-producing cells
WO2001023528A8 (en) Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
AU641488B2 (en) Human hematopoietic stem cell
AU2001282123A1 (en) Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
WO2005121369A3 (en) Rna-containing microvesicles and methods therefor
CA2131385A1 (en) Methods, compositions and devices for maintaining and growing human stem or hematopoietic cells
MX9707920A (es) Conversion en dos pasos de conjugados de isoflavona de proteina vegetal a agluconas.
WO1999053022A3 (en) Selection of lineage specific cells after differentiation of progenitor cells
WO2000034442A3 (en) Application of shear flow stress to smooth muscle cells for the production of implantable structures
CA2051375A1 (en) Process and compositions for the isolation of human relaxin
WO2000006703A3 (en) Inhibition of graft versus host disease
CN107012191A (zh) 一种分子量范围可控的多肽的制备方法及装置
AU5079200A (en) Lycopen production method
CA2241569A1 (en) Methods for producing taxane-type diterpenes
DE60111490D1 (de) Herstellung von vakzinen unter der verwendung von hybrid-zellen
Hinterstoisser et al. Detection of chlorophyllide in chlorophyll-free plasma membrane preparations from Anacystis nidulans
CN104962481A (zh) 一种桦褐孔菌菌核培养基及其制备方法
AU2002342564A1 (en) Bio-artificial trachea implant and a method for producing the same
WO2001087935A3 (en) Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)